TP-0903 reduces anti-apoptotic proteins like BCL-2, MCL-1, and XIAP, and enhances dose-dependent chronic lymphocytic leukemia (CLL) cell death (54, 55). The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.